PGX Testing
PGX Testing (Pharmacogenomics)
Problem
In 2016, there were approximately 4.45 billion prescriptions issued all over the United States. While many of these medications are useful and often live saving, there are many cases of:
Adverse reactions to medications resulting in hospital visits (overdosing).
Adverse reactions to medications resulting in death.
Medication doses altered due to ineffectiveness of the medication.
Researchers estimate that commonly prescribed medications may not work in up to 60 percent of patients.
The problem: healthcare providers simply don’t have the relevant data based on their patient’s genetic metabolic pathways to accurately determine:
Their rate of metabolism for a given medication
Reaction:
Health care providers continually prescribe medications which leave a significant margin for error. Patients take medications often on a trial-and-error basis. Doses having to be adjusted based on the patient’s response.
The most effective medication and dosage
Solution
PGX Genetic Testing Can Help
PGX testing can show how a patient’s body is likely to metabolize many common medications. This allows healthcare providers to act on the results to prescribe medications with less risk of side effects, including overdosing or ineffectiveness. Not all people respond to the standard dose. Genetic testing helps the provider to select the right drug and best dose for the patient.
Patients are either: Poor, intermediate, normal, or rapid metabolizers of medications.
Types of Genetic Testing Panels
CARDIAC
GENERAL
PAIN
PSYCH
Each panel looks for gene variations affecting the body’s enzymes work.
Genetic Testing USA’ laboratory panels look for gene variations that affect one family of enzymes. This family is called the *P450 enzymes.” These enzymes break down up to 80 percent of all medications.
Additional Benefits
PGX testing allows patients to avoid adverse drug reactions, maximize drug efficacy and prescribe with more confidence.
Fast turnaround – All samples are quickly processed, and results reported, normally within three working days of receipt.
Clear, understandable reports – PGX Genotype Panels results are clearly presented with the patient’s needs in mind.
Peer-to-peer support – If you have questions or need more detailed information on test results, MD support specialists are available for consultation.
Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease At Um Diagnostics, we provide health and wellness solutions, including laboratory testing for wellness monitoring, informational, and educational purposes. Please note that, with the exception of specific diagnostic test panels (listed here), our tests are not designed to diagnose or treat medical conditions. They should not replace professional medical advice, diagnosis, or treatment. Additionally, due to regulatory restrictions, our tests are currently unavailable in NY.
Copyright © 2024 – umds.org – All Rights Reserved
